Cite
MLA Citation
D Forton et al.. “OC-010 Final efficacy and safety in hcv genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin: topaz-i results from the united kingdom and ireland.” Gut, vol. 66, n.d., pp. A5–A6. http://access.bl.uk/ark:/81055/vdc_100144723712.0x00003b